Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Aptevo Therapeutics Inc. (APVO) had Income from Continuous Operations of $-5.81M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-5.90M |
|
-- |
|
-- |
|
$6.00M |
|
$-6.00M |
|
$0.19M |
|
$-5.81M |
|
$-5.81M |
|
$-5.81M |
|
|
Income from Continuous Operations |
$-5.81M |
$-5.81M |
|
$-5.81M |
|
$-6.00M |
|
$-5.92M |
|
0.32M |
|
0.32M |
|
$1683.05 |
|
$1683.05 |
|
| Balance Sheet Financials | |
$23.08M |
|
$0.30M |
|
$4.11M |
|
$27.19M |
|
$6.05M |
|
-- |
|
$3.76M |
|
$9.81M |
|
$17.38M |
|
$17.38M |
|
$17.38M |
|
1.00M |
|
| Cash Flow Statement Financials | |
$-25.59M |
|
-- |
|
$38.50M |
|
$8.71M |
|
$21.62M |
|
$12.90M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-33.40% |
|
-33.40% |
|
-21.35% |
|
-33.40% |
|
$17.42 |
|
$-81.11 |
|
$-81.11 |
|